دورية أكاديمية
أعرض في EDS

Chronic kidney disease: detect, diagnose, disclose-a UK primary care perspective of barriers and enablers to effective kidney care.

التفاصيل البيبلوغرافية
العنوان: Chronic kidney disease: detect, diagnose, disclose-a UK primary care perspective of barriers and enablers to effective kidney care.
المؤلفون: Stewart S; The University of Manchester, Centre for Primary Care & Health Services Research, Manchester, UK. stuart.stewart@manchester.ac.uk.; Donal O'Donoghue Renal Research Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK. stuart.stewart@manchester.ac.uk.; Rochdale Care Organisation, Northern Care Alliance NHS Foundation Trust, Manchester, UK. stuart.stewart@manchester.ac.uk., Kalra PA; Donal O'Donoghue Renal Research Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK., Blakeman T; The University of Manchester, Centre for Primary Care & Health Services Research, Manchester, UK., Kontopantelis E; The University of Manchester, Centre for Primary Care & Health Services Research, Manchester, UK., Cranmer-Gordon H; Donal O'Donoghue Renal Research Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK., Sinha S; Donal O'Donoghue Renal Research Centre, Northern Care Alliance NHS Foundation Trust, Manchester, UK.; Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
المصدر: BMC medicine [BMC Med] 2024 Aug 15; Vol. 22 (1), pp. 331. Date of Electronic Publication: 2024 Aug 15.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BioMed Central, 2003-
مواضيع طبية MeSH: Renal Insufficiency, Chronic*/diagnosis , Renal Insufficiency, Chronic*/therapy , Primary Health Care*, Humans ; United Kingdom ; Practice Guidelines as Topic
مستخلص: Chronic kidney disease (CKD) is a global public health problem with major human and economic consequences. Despite advances in clinical guidelines, classification systems and evidence-based treatments, CKD remains underdiagnosed and undertreated and is predicted to be the fifth leading cause of death globally by 2040. This review aims to identify barriers and enablers to the effective detection, diagnosis, disclosure and management of CKD since the introduction of the Kidney Disease Outcomes Quality Initiative (KDOQI) classification in 2002, advocating for a renewed approach in response to updated Kidney Disease: Improving Global Outcomes (KDIGO) 2024 clinical guidelines. The last two decades of improvements in CKD care in the UK are underpinned by international adoption of the KDIGO classification system, mixed adoption of evidence-based treatments and research informed clinical guidelines and policy. Interpretation of evidence within clinical and academic communities has stimulated significant debate of how best to implement such evidence which has frequently fuelled and frustratingly forestalled progress in CKD care. Key enablers of effective CKD care include clinical classification systems (KDIGO), evidence-based treatments, electronic health record tools, financially incentivised care, medical education and policy changes. Barriers to effective CKD care are extensive; key barriers include clinician concerns regarding overdiagnosis, a lack of financially incentivised care in primary care, complex clinical guidelines, managing CKD in the context of multimorbidity, bureaucratic burden in primary care, underutilisation of sodium-glucose co-transporter-2 inhibitor (SGLT2i) medications, insufficient medical education in CKD, and most recently - a sustained disruption to routine CKD care during and after the COVID-19 pandemic. Future CKD care in UK primary care must be informed by lessons of the last two decades. Making step change, over incremental improvements in CKD care at scale requires a renewed approach that addresses key barriers to detection, diagnosis, disclosure and management across traditional boundaries of healthcare, social care, and public health. Improved coding accuracy in primary care, increased use of SGLT2i medications, and risk-based care offer promising, cost-effective avenues to improve patient and population-level kidney health. Financial incentives generally improve achievement of care quality indicators - a review of financial and non-financial incentives in CKD care is urgently needed.
(© 2024. The Author(s).)
References: BMJ Qual Saf. 2012 Aug;21(8):700-8. (PMID: 22556307)
BMJ. 2009 Aug 11;339:b2803. (PMID: 19671932)
EClinicalMedicine. 2024 Jan 19;68:102426. (PMID: 38304744)
N Engl J Med. 2018 Sep 06;379(10):948-957. (PMID: 30184445)
Can Fam Physician. 2023 Apr;69(4):295. (PMID: 37072196)
Nephrol Dial Transplant. 2016 Nov;31(11):1864-1870. (PMID: 26681733)
Am J Kidney Dis. 2008 Jul;52(1):118-27. (PMID: 18589216)
BMC Res Notes. 2015 Nov 11;8:668. (PMID: 26559491)
Br J Gen Pract. 2020 Mar 26;70(693):e285-e293. (PMID: 32041766)
Nephron Clin Pract. 2011;117(3):c213-24. (PMID: 20805694)
Nephrol Dial Transplant. 2023 May 4;38(5):1170-1182. (PMID: 35869974)
Nephrol Dial Transplant. 2023 Jan 23;38(1):119-128. (PMID: 35689668)
Kidney Int. 2021 Jan;99(1):34-47. (PMID: 33127436)
Nephrol Dial Transplant. 2018 Aug 1;33(8):1373-1379. (PMID: 29045728)
Lancet. 2016 Jun 4;387(10035):2323-2330. (PMID: 27059888)
Kidney Int. 2005 Jun;67(6):2089-100. (PMID: 15882252)
Kidney Int Rep. 2021 Jun 30;6(8):2028-2030. (PMID: 34386651)
BMJ. 2023 Jul 31;382:e074265. (PMID: 37524389)
BMC Nephrol. 2020 Mar 12;21(1):83. (PMID: 32160886)
PLoS Comput Biol. 2021 Jan 22;17(1):e1008619. (PMID: 33481773)
BMJ. 2023 Mar 22;380:e072098. (PMID: 36948515)
Clin Kidney J. 2023 Mar 15;16(9):1375-1383. (PMID: 37664574)
Kidney Med. 2022 Jun 09;4(7):100497. (PMID: 35789757)
Diagn Progn Res. 2023 Oct 5;7(1):22. (PMID: 37798742)
BMC Nephrol. 2014 Apr 22;15:64. (PMID: 24755164)
BMC Nephrol. 2018 Jul 19;19(1):183. (PMID: 30025520)
J Intern Med. 2021 Jul;290(1):166-178. (PMID: 33452733)
N Engl J Med. 2023 Jan 12;388(2):117-127. (PMID: 36331190)
Soc Sci Med. 2011 Sep;73(6):801-7. (PMID: 21669483)
RMD Open. 2020 Jul;6(2):. (PMID: 32699043)
BMJ Open. 2020 Aug 13;10(8):e038423. (PMID: 32792448)
Br J Gen Pract. 2019 Jul;69(684):e454-e461. (PMID: 31160369)
Nature. 2020 Aug;584(7821):430-436. (PMID: 32640463)
Soc Sci Med. 2015 Apr;131:31-9. (PMID: 25748112)
BMJ Open. 2011 Dec 19;1(2):e000308. (PMID: 22184586)
Lancet. 2020 Feb 29;395(10225):709-733. (PMID: 32061315)
Br J Gen Pract. 2015 Jul;65(636):e469-77. (PMID: 26120137)
J Am Heart Assoc. 2019 Jan 22;8(2):e010640. (PMID: 30651020)
BMJ. 2021 Feb 18;372:n421. (PMID: 33602672)
Ann Intern Med. 2021 Feb;174(2):183-191. (PMID: 33166224)
Kidney Int. 2015 Aug;88(2):396-403. (PMID: 25874600)
Kidney Int. 2007 Jul;72(1):92-9. (PMID: 17440495)
BMC Nephrol. 2020 Jan 10;21(1):10. (PMID: 31924178)
PLoS Med. 2019 Nov 6;16(11):e1002955. (PMID: 31693662)
BMJ. 2024 Apr 15;385:e078063. (PMID: 38621801)
Kidney Int. 2011 Jul;80(1):17-28. (PMID: 21150873)
Kidney Med. 2020 Feb 21;2(3):248-257. (PMID: 32734244)
BMJ. 2013 Jul 29;347:f4298. (PMID: 23900313)
Br J Gen Pract. 2012 Apr;62(597):172-3. (PMID: 22520891)
Nat Rev Nephrol. 2020 Dec;16(12):705-706. (PMID: 32848205)
PLoS One. 2014 Oct 16;9(10):e109135. (PMID: 25330169)
Kidney Int. 2024 Apr;105(4S):S117-S314. (PMID: 38490803)
PLoS One. 2019 Aug 22;14(8):e0221325. (PMID: 31437198)
معلومات مُعتمدة: AHPF_001_20220705 Kidney Research UK
فهرسة مساهمة: Keywords: COVID-19; Chronic kidney disease; Detection; Incentivised care; Integrated care systems; Population health; Primary care; Primary care networks; Screening
تواريخ الأحداث: Date Created: 20240815 Date Completed: 20240815 Latest Revision: 20240818
رمز التحديث: 20240818
مُعرف محوري في PubMed: PMC11328380
DOI: 10.1186/s12916-024-03555-0
PMID: 39148079
قاعدة البيانات: MEDLINE
الوصف
تدمد:1741-7015
DOI:10.1186/s12916-024-03555-0